Zhongnan Medical Journal Press

Home Results

A total of 12 result was found. Results that relate to Fatty liver

Prevalence and influencing factors of MAFLD among residents aged 65 years and older in a district of Wuhan

Published on New Medicine 2022,32(1):120-126.
16491 times 4169 times

Wen-Shuang WEI Fang LI Ya-Qiong YAN Yan GUO Qing LIU

Metabolic associated fatty liver disease MAFLD Prevalence Influencing factors
Details
Effects of Shugan Jiangzhi decoction combined with L-ornithine-L-aspartate in fatty liver after viral hepatitis

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):472-479.
7561 times 1526 times

Xiao-Dan ZHANG Jiang-Wei SU Jing LIANG Ping LIANG

Fatty liver Shugan Jiangzhi decoction L-ornithine-L-aspartate Viral hepatitis
Details
Exploration of the pharmacodynamic substance basis and mechanism of Honghua Qinggan Shisanwei pills in treating non-alcoholic fatty liver based on HPLC-Q-Exactive MS and network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2024,28(3):365-380.
8156 times 1610 times

HAO Xia LIU Jing ZHANG Qian LI Jun

Honghua Qinggan Shisanwei pills Non-alcoholic fatty liver disease High performance liquid chromatography-Q-Exactive mass spectrometry Network pharmacology Molecular docking Insulin resistance Oxidative stress
Details
Prevalence and risk factors of nonalcoholic fatty liver disease in overweight and obese children: a Meta-analysis

Published on Journal of Mathematical Medicine 2024,37(12):935-946.
11938 times 1773 times

XIANG Feng CAO Xuehua HU Wanqin JIA Yu

Nonalcoholic fatty liver disease Overweight Obese Children Incidence Body mass index Meta-analysis
Details
Effectiveness of different immunonutrients in the treatment of nonalcoholic fatty liver disease: a network Meta-analysis

Published on Journal of Mathematical Medicine 2025,38(3):214-224.
9195 times 1614 times

LYU Jie MA Li ZHANG Qian SUN Shuxin JIA Yatian ZHANG Yihua

Immunonutrient Nonalcoholic fatty liver disease Curative effect Network Meta-analysis
Details
Research progress on the role and mechanism of Chitooligosaccharides in improving metabolic dysfunction-associated fatty liver disease

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1422-1430.
6092 times 976 times

ZHONG Li HUANG Guidong

Chitooligosaccharides Metabolic dysfunction-associated fatty liver disease Lipid-Lowering mechanism Research progress
Details
Effect of regulating miR-29b-3p/FoxO3 axis by asiaticoside on alleviating liver injury in rats with non-alcoholic fatty liver disease

Published on New Medicine 2025,35(10):1165-1172.
4777 times 878 times

TAN Jie LIU Meng TIAN Xia HAN Zheng ZHU Qingxi ZHAN Ting CHEN Mingtao CHEN Aifang HUANG Min

Asiaticoside Non-alcoholic fatty liver disease Liver injury MicroRNA-29b-3p/forkhead box O3
Details
Systematic biological study on traditional Chinese medicine treatment for non-alcoholic fatty liver disease: analysis of compatibility patterns and multi-target synergistic mechanisms

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1878-1886.
6062 times 863 times

ZHANG Zhenwei ZHANG Nana ZHANG Hua SHI Lei YU Qiuxiang

Non-alcoholic fatty liver disease Network pharmacology Molecular mechanism Chemical components of traditional Chinese medicine Collaborative efficiency enhancement
Details
Association of sleep duration and sleep quality with metabolic associated fatty liver disease among Wuhan subway workers

Published on New Medicine 2025,35(11):1256-1264.
4723 times 837 times

PENG Rong LIU Junling SHI Bin TAO Yi YAN Xueping HE Zhenyu

Sleep duration Sleep quality Metabolic associated fatty liver disease Mediation effect
Details
Bibliometric analysis of non-alcoholic fatty liver disease mechanisms and pharmacological treatment: research hotspots and trends (2014—2024)

Published on Frontiers in Pharmaceutical Sciences 2026,30(2):284-293.
1644 times 416 times

FENG Jiaxin YIN Jing LI Qiuping TAN Liuping TAO Xiaojing YANG Xiaomin ZHANG Bei ZHANG Hongping

Non-alcoholic fatty liver disease Visualization analysis Mechanisms Bibliometrics Research hotspots and trends CiteSpace VOSviewer Knowledge graph
Details
The application of Mendelian randomization in metabolic associated fatty liver disease based on bibliometric analysis

Published on Journal of Mathematical Medicine 2026,39(3):162-178.
1814 times 479 times

GAO Jiangfei SHI Xinyu ZHENG Wanyi MAIMAITIAILI Maierhaba WANG Xu XU Xiuyun WU Na

Mendelian randomization Metabolic associated fatty liver disease Bib-liometrics Visualization analysis
Details
Disease burden of metabolic dysfunction-associated steatotic liver disease in the elderly population globally and in China from 1990 to 2021

Published on New Medicine 2026,36(4):428-437.
751 times 243 times

ZHANG Qiang ZHAO Xiaoxiao WANG Haibo XU Peng WANG Yaxing ZHAO Xinke LIU Fan LI Jiali HE Tao CHEN Zhengtao Ding Yunhan KE Lixin LI Jieyun XUN Yangqin LU Cuncun

Metabolic dysfunction-associated steatotic liver disease Non-alcoholic fatty liver disease Older adult Disease burden Prediction model
Details